---
Structure-based drug design as an enabling tool toward novel therapeutics in cancer, neurodegenerative disorders and infectious diseases
16 febbario 2023, ore 11:00.
Cittadella Universitaria di Monserrato, blocco A, aula 109
Selective histone deacetylase 6 inhibition: tracking the journey from established anticancer strategy to innovative therapeutic option in rare diseases
17 febbario 2023, ore 11:00.
Cittadella Universitaria di Monserrato, blocco A, aula 112
Locandina dell’evento allegata.